Literature DB >> 15322659

Analysis of heart rate variability in hypertensive patients before and after treatment with angiotensin II-converting enzyme inhibitors.

Antônio da Silva Menezes1, Humberto Graner Moreira, Murilo Tavares Daher.   

Abstract

OBJECTIVE: To compare heart rate variability in normotensive and hypertensive individuals and to observe the behavior of the autonomic nervous system after treatment with angiotensin II-converting enzyme inhibitors.
METHOD: The study comprised 286 patients diagnosed with arterial hypertension (AH) for the first time and divided into 4 groups according to diastolic blood pressure (DBP) levels: group A -- DBP<90 mmHg; group B -- DBP 90-99 mmHg; group C -- DBP 100-109 mmHg; group D -- DBP>110 mmHg. Group A (110 healthy individuals) and group C (79 patients with moderate AH) underwent 24-hour Holter-ECG with analysis of heart rate variability in time domain (TD) and frequency domain (FD). The group C patients were treated with ACE inhibitors for 3 months, and, after this period, they underwent a new 24-hour Holter-ECG study for assessing heart rate variability, the values being compared with those of normotensive individuals.
RESULTS: The SDNN and PNN50 parameters (TD), and the LF spectrum (FD) were significantly different in the 2 groups, with clearly reduced values in hypertensive individuals (P<0.05). Group C patients, after treatment with ACE inhibitors, showed a recovery in all variables of heart rate variability, achieving values close to those of normotensive individuals.
CONCLUSION: Heart rate variability was reduced in hypertensive patients when compared with that in normotensive individuals, indicating a decrease in the baroreceptor reflex. A functional autonomic adjustment after the antihypertensive treatment with ACEI was observed, indicating recovery of parasympathetic tonus.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15322659     DOI: /S0066-782X2004001400008

Source DB:  PubMed          Journal:  Arq Bras Cardiol        ISSN: 0066-782X            Impact factor:   2.000


  9 in total

1.  Associations between Heart Rate Variability Parameters and Hemodynamic Profiles in Patients with Primary Arterial Hypertension, Including Antihypertensive Treatment Effects.

Authors:  Małgorzata Maciorowska; Paweł Krzesiński; Robert Wierzbowski; Beata Uziębło-Życzkowska; Grzegorz Gielerak
Journal:  J Clin Med       Date:  2022-06-29       Impact factor: 4.964

2.  Evaluation of the indications and arrhythmic patterns of 24 hour Holter electrocardiography among hypertensive and diabetic patients seen at OAUTHC, Ile-Ife Nigeria.

Authors:  Rasaaq A Adebayo; Amanze N Ikwu; Michael O Balogun; Anthony O Akintomide; Tuoyo O Mene-Afejuku; Victor O Adeyeye; Olaniyi J Bamikole; Luqman A Bisiriyu; Olufemi E Ajayi; Suraj A Ogunyemi; Omolola A Oketona
Journal:  Diabetes Metab Syndr Obes       Date:  2014-11-26       Impact factor: 3.168

3.  Elastase-2, a Tissue Alternative Pathway for Angiotensin II Generation, Plays a Role in Circulatory Sympathovagal Balance in Mice.

Authors:  Christiane Becari; Marina T Durand; Alessander O Guimaraes; Renata M Lataro; Cibele M Prado; Mauro de Oliveira; Sarai C O Candido; Paloma Pais; Mauricio S Ribeiro; Michael Bader; Joao B Pesquero; Maria C O Salgado; Helio C Salgado
Journal:  Front Physiol       Date:  2017-03-23       Impact factor: 4.566

4.  Comparative study of cardiac autonomic status by heart rate variability between under-treatment normotensive and hypertensive known type 2 diabetics.

Authors:  Jayesh D Solanki; Sanket D Basida; Hemant B Mehta; Sunil J Panjwani; Bhakti P Gadhavi
Journal:  Indian Heart J       Date:  2016-08-02

5.  Heart Rate and its Variability Assessed by Spectral Analysis in Elderly Subjects with Orthostatic Hypotension: A Case-Control Study.

Authors:  Rose Mary Ferreira Lisboa da Silva; Carlos Eduardo de Souza Miranda; Maira Tonidandel Barbosa; Maria Aparecida Camargos Bicalho
Journal:  Arq Bras Cardiol       Date:  2018-03-19       Impact factor: 2.000

6.  Efficacy of risk stratification protocols and clinical, physical, and biochemical parameters to previse signals and symptoms during cardiovascular rehabilitation programs: Protocol for an observational trial.

Authors:  Laís Manata Vanzella; Carolina Takahashi; Felipe Ribeiro; Isabelle Maina Lima; Anne Kastelianne França da Silva; Diego Giulliano Destro Christófaro; Luiz Carlos Marques Vanderlei
Journal:  Medicine (Baltimore)       Date:  2019-06       Impact factor: 1.817

7.  Is It Safe for Patients With Cardiac Channelopathies to Undergo Routine Dental Care? Experience From a Single-Center Study.

Authors:  Ana Carolina Guimarães Oliveira; Itamara Lucia Itagiba Neves; Luciana Sacilotto; Natália Quintella Sangiorgi Olivetti; Marcela Alves Dos Santos-Paul; Tânia Cristina Pedroso Montano; Cíntia Maria Alencar Carvalho; Tan Chen Wu; Cesar José Grupi; Sílvio Alves Barbosa; Carlos Alberto Pastore; Nelson Samesima; Denise Tessariol Hachul; Maurício Ibrahim Scanavacca; Ricardo Simões Neves; Francisco Carlos Costa Darrieux
Journal:  J Am Heart Assoc       Date:  2019-07-19       Impact factor: 5.501

8.  Association of cardiovascular risk using non-linear heart rate variability measures with the framingham risk score in a rural population.

Authors:  Herbert F Jelinek; Hasan Md Imam; Hayder Al-Aubaidy; Ahsan H Khandoker
Journal:  Front Physiol       Date:  2013-07-26       Impact factor: 4.566

9.  Autonomic dysfunction in mild cognitive impairment: evidence from power spectral analysis of heart rate variability in a cross-sectional case-control study.

Authors:  Paola Nicolini; Michele M Ciulla; Gabriella Malfatto; Carlo Abbate; Daniela Mari; Paolo D Rossi; Emanuela Pettenuzzo; Fabio Magrini; Dario Consonni; Federico Lombardi
Journal:  PLoS One       Date:  2014-05-06       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.